Study: Transplant Possible After Immunotherapy for | Newswise

Study: Transplant Possible After Immunotherapy for | Newswise

Newswise — LOS ANGELES (Aug. 8, 2024) — Liver transplant is considered the best treatment for liver cancer, but only available for patients with early-stage disease. Now a study led by Cedars-Sinai Cancer investigators has concluded that immunotherapy could make liver transplant an option for patients with later-stage cancer as well. The international study was published in the…

Read More
Water droplets on a butterfly’s wing among winners in microscopic video competition | CBC News

Water droplets on a butterfly’s wing among winners in microscopic video competition | CBC News

It’s not every day we get to see the tiny world that exists beyond our vision, but that’s what the Nikon Small World in Motion competition is all about. This is the 14th year of the competition, where past winners revealed extraordinary insights into things like the stomach contents of a termite, human cells fusing and dying during…

Read More
New learning hub for volunteer firefighters in Oxford County will bring variety of training | CBC News

New learning hub for volunteer firefighters in Oxford County will bring variety of training | CBC News

Volunteer firefighter training will become more accessible in Oxford County as five of its rural fire service groups have turned into a regional training centre (RTC) for the Ontario Fire College. The Norwich Fire Service along with departments in Blandford-Blenheim, South-West Oxford, Zorra and East Zorra-Tavistock will soon be offering in-house training courses to anyone across the province who wants to work…

Read More
Study: Transplant Possible After Immunotherapy for | Newswise

Roswell Park-Designed Treatment Regimen Doubles Pr | Newswise

Alternating pazopanib and bevacizumab found superior to pazopanib alone Strategy aims to delay onset of resistance to pazopanib Study reveals median progression-free survival of 23.3 months Newswise — BUFFALO, N.Y. — A phase 1/2 clinical trial for patients with metastatic kidney cancer demonstrated that a novel two-agent treatment regimen developed at Roswell Park Comprehensive Cancer…

Read More